|
Nov 30, 1999
Israel: A New Lung Cancer Pilot in Soroka Hospital
Matthew Oser
USA
Matthew Oser
Speaker of: Israel: A New Lung Cancer Pilot in Soroka Hospital
Matthew G. Oser MD, PhD, is a Physician-Scientist in the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute (DFCI) and an Assistant Professor of Medicine at Harvard Medical School. After earning his MD and PhD from the Albert Einstein College of Medicine, Dr. Oser completed his internship and residency in Medicine at Brigham and Women’s Hospital, Boston. He subsequently completed medical oncology fellowship training at the Dana-Farber Cancer Institute/Massachusetts General Hospital combined program, and performed his post-doctoral work in Dr. William G. Kaelin Jr’s laboratory at DFCI. Since 2019, he is the principal investigator of his own laboratory at DFCI.
Dr. Oser’s research focuses on using CRISPR/Cas9 to understand mechanisms that control neuroendocrine differentiation in SCLC and to identify novel targeted therapies for SCLC. Dr. Oser has been the recipient of a Lung Cancer Research Foundation Career Development Award, a NIH K08 career development award, and a Damon Runyon Clinical Investigator Award.
The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ISLB. The mention of any product, service, organization, activity, or therapy should not be construed as an ISLB endorsement.
Recent Episodes
Nov 01, 2025
Nov 23, 2024
Nov 21, 2023
Nov 30, 1999
David MacPherson
Nov 30, 1999
Kate Sutherland
Nov 30, 1999
Portia Thomas
Nov 30, 1999
Simon Heeke
Nov 30, 1999
Bruno Paiva
Nov 30, 1999
Catherine Meador
Nov 30, 1999
Carmen Garrido
Nov 30, 1999
Heather Wakelee
